EUCTR2010-023827-34-IT进行中（未招募）不适用
PHASE III CLINICAL TRIAL TO ASSESS THE ADDED ROLE OF 68Ga-DOTANOC PET-CT IN PATIENTS WITH NEUROENDOCRINE TUMORS - ND
POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI0 个研究点开始时间: 2010年12月24日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •->18 years patients with known neuroendocrine tumors for staging, therapy response evaluation or restaging;
- •- availability to participate in the study expressed by a written informed consent;
- •- patients able to be submitted to PET-CT.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •- patients not able to partecipate in this protocol study.
研究者
相似试验
进行中（未招募）
1 期
PHASE III CLINICAL TRIAL FOR THE EVALUATION OF THE EFFICACY AND SAFETY OF A PARACETAMOL + IBUPROFEN COMBINATION IN PATIENTS WITH mENSTRUAL PAIEUCTR2018-000138-37-ESaboratorios Farmalíder S.A.480
进行中（未招募）
不适用
X01-315-02 / ?A Phase 3 Clinical Trial to Evaluate the Safety and Efficacy of Treatment with 2 mg Intralesional Allovectin-7R Compared to Dacarbazine (DTIC) or Temozolomide (TMZ) in Subjects with Recurrent Metastatic Melanoma? - Allovectin-7R Immunotherapy for Metastatic Melanoma (A.I.M.M.)Recurrent metastatic melanomaMedDRA version: 9.1Level: LLTClassification code 10027481Term: Metastatic melanomaEUCTR2007-004120-21-ITVICAL INCORPORATED375
尚未招募
3 期
A study researching the effect of upfront cytoreductive surgery with or without intraperitoneal lavage under heated conditions (HIPEC) in subjects with stage III ovarian cancer - OVHIPEC-2CTRI/2023/08/056165Antoni Van Leeuwenhoek Netherlands Cancer Institute
进行中（未招募）
不适用
TOP TRIAL. A RANDOMISED PHASE III CLINICAL TRIAL OF TRASTUZUMAB (HERCEPTIN) OPTIMIZATION IN PATIENTS WITH LOCALLY ADVANCED AND/OR METASTATIC BREAST CANCER OVEREXPRESSING HER2 AFTER A FIRST LINE CHEMOTHERAPY PLUS TRASTUZUMAB - TOP TRIAWomen with locally advanced or metastatic breast cancer over expressing HER2 who have been previously treated with a first line chemotherapy plus trastuzumab.MedDRA version: 9.1Level: LLTClassification code 10006279Term: Breast neoplasmEUCTR2007-005021-30-ITREGIONE LOMBARDIA - DIREZIONE GENERALE SANITA'
进行中（未招募）
不适用
A Phase III, Randomized, Clinical Trial to Evaluate the Safety and Efficacy of the Addition of Sitagliptin in Patients With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on a Sulfonylurea in Combination With MetformiDiabetes Mellitus type 2MedDRA version: 12.1Level: LLTClassification code 10067585Term: Type 2 diabetes mellitusEUCTR2010-018318-62-HUMerck & Co., Inc.424